You are here

  • Home
  • Archive
  • Volume 71, Issue 4
  • Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial

Citation Tools

Article menu
Stomach
Original research
Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sundar R, Barr Kumarakulasinghe N, Huak Chan Y, et al
Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial
Gut 2022;71:676-685.